Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
"Despite rising demand, India's obesity market remains largely under-penetrated, offering significant headroom for both innovators and generic entrants," Sheetal Sapale, vice-president (commercial) at Pharmarack said.Entry of low-priced generics from March after semaglutide (key ingredient in the blockbuster weight-loss jab) loses patent protection, along with potential price cuts by innovators, is expected to further accelerate growth in the fastest growing therapy
The authors estimate that these participants were representative of more than 20 million U.S
What is L Carnitine L Tartrate
For people of reproductive age, fertility implications are worth discussing with a healthcare provider
Many people are aware of the more popular version of semaglutide, Ozempic, but Ozempic is no longer approved for weight loss in the UK
